<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Front Pharmacol</journal-id><journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id><journal-title-group><journal-title>Frontiers in Pharmacology</journal-title></journal-title-group><issn pub-type="epub">1663-9812</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7982472</article-id><article-id pub-id-type="publisher-id">638210</article-id><article-id pub-id-type="doi">10.3389/fphar.2021.638210</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmacology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Beyond Alkaloids: Novel Bioactive Natural Products From <italic>Lobelia</italic> Species</article-title><alt-title alt-title-type="left-running-head">Zheng et al.</alt-title><alt-title alt-title-type="right-running-head">Novel Bioactive Compounds from <italic>Lobelia</italic></alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Qinfang</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/972829/overview"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Ye</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="c001">*</xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/981002/overview"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Shuihan</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><xref ref-type="corresp" rid="c001">*</xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/880862/overview"/></contrib></contrib-group><aff id="aff1">
<label><sup>1</sup></label>Hunan Academy of Chinese Medicine, Hunan University of Chinese Medicine, <addr-line>Changsha</addr-line>, <country>China</country>
</aff><aff id="aff2">
<label><sup>2</sup></label>Key Laboratory of Dong Medical Research of Hunan Province, Hunan University of Medicine, <addr-line>Huaihua</addr-line>, <country>China</country>
</aff><aff id="aff3">
<label><sup>3</sup></label>2011 Collaboration and Innovation Center for Digital Chinese Medicine in Hunan, <addr-line>Changsha</addr-line>, <country>China</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited by:</bold>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/540756/overview">Shuai Ji</ext-link>, Xuzhou Medical University, China</p></fn><fn fn-type="edited-by"><p>
<bold>Reviewed by:</bold>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/424497/overview">Yogesh Chandra Tripathi</ext-link>, Forest Research Institute, India</p><p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/109889/overview">David M. Pereira</ext-link>, University of Porto, Portugal</p><p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1167330/overview">Joshua Kibet</ext-link>, Egerton University, Kenya</p></fn><corresp id="c001">*Correspondence: Ye Wang, <email>hhyzwy@126.com</email>; Shuihan Zhang, <email>zhangshuihan0220@126.com</email></corresp><fn fn-type="other"><p>This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology</p></fn></author-notes><pub-date pub-type="epub"><day>08</day><month>3</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>12</volume><elocation-id>638210</elocation-id><history><date date-type="received"><day>05</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>25</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2021 Zheng, Wang and Zhang.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Zheng, Wang and Zhang</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>In this work, we reviewed the progress in the phytochemical and biological investigations of bioactive components derived from medicinally valuable <italic>Lobelia</italic> species. In the last 60&#x000a0;years, <italic>Lobelia</italic> has garnered significant attention from the phytochemist from around the world, majorly due to the discovery of bioactive piperidine alkaloids (e.g., lobinaline and lobeline) in the early 1950s. Later, lobeline underwent clinical trials for several indications including the treatment of attention deficit hyperactivity disorder and a multicenter phase three trial for smoking cessation. Subsequently, several other alkaloids derived from different species of <italic>Lobelia</italic> were also investigated for their pharmacological characteristics. However, in the last few years, the research focus has started shifting to the characterization of the other novel chemical classes. The major shift has been noticed due to the structurally similar alkaloid components, which essentially share similar pharmacological, physicochemical, and toxicological profiles. In this review, we present an up-to-date overview of their progress with special attention to understanding the molecular mechanisms of the novel bioactive components.</p></abstract><kwd-group><kwd>lobelia</kwd><kwd>alkaloids</kwd><kwd>natural products</kwd><kwd>lobeline</kwd><kwd>bioactive compounds</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>
<italic>Lobelia</italic>, named after the botanist Matthias de lobel, is a large genus of medicinally valuable flowering plants belonging to the Campanulaceae family comprising more than 450 species distributed predominantly in tropical and temperate regions of the world. Several species of <italic>Lobelia</italic> are traditionally used in different folk medicine to treat various diseases. Among them, <italic>Lobelia inflata</italic>, <italic>Lobelia nicotianaefolia</italic>, <italic>Lobelia cardinalis, Lobelia chinensis</italic>, <italic>Lobelia laxiflora</italic>, <italic>Lobelia trigona</italic> Roxb., <italic>Lobelia siphilitica</italic> L., <italic>Lobelia sessilifoilia</italic> Lamb, <italic>Lobelia polyphylla</italic>, and <italic>Lobelia pyramidalis</italic> Wall. are some of the frequently used <italic>Lobelia</italic> species. The phytochemical researches of these species led to the discovery of several novel bioactive secondary metabolites.</p><p>The earliest scientific report on the pharmacological use of <italic>Lobelia</italic> species in diseased conditions dates back to 1828 (<xref rid="B3" ref-type="bibr">Andrew, 1828</xref>). More than a century later (in 1950), Tondeur and Charlier reported the extraction and pharmacological activities of alkaloids from <italic>Lobelia suavibracteata</italic> (Haumann) and <italic>Lobelia giberroa</italic> (Hemsl.) (<xref rid="B10" ref-type="bibr">Charlier and Tondeur, 1950</xref>; <xref rid="B64" ref-type="bibr">Tondeur and Charlier, 1950</xref>). In the 1950s, other studies began to reveal the distinctive pharmacological properties of the alkaloid constituents derived from different <italic>Lobelia</italic> species (<xref rid="B34" ref-type="bibr">Lendle and Richter, 1950</xref>). One of the alkaloids that garnered major attention was lobeline 1 (<xref ref-type="fig" rid="F1">Figure 1</xref>), which was primarily derived from the aerial parts of <italic>Lobelia inflata,</italic> (<xref rid="B28" ref-type="bibr">Kaczmarek and Steinegger, 1959</xref>; <xref rid="B47" ref-type="bibr">Saldanha et al., 1959</xref>). In the subsequent decades, the studies on the prospective evaluation of the use of lobeline have seen unprecedented advances, including but not limited to smoking cessation (<xref rid="B18" ref-type="bibr">Glover et al., 2010</xref>; <xref rid="B55" ref-type="bibr">Stead and Hughes, 2012</xref>), treatment of drug and alcohol abuse (<xref rid="B5" ref-type="bibr">Bell et al., 2009</xref>; <xref rid="B20" ref-type="bibr">Hart et al., 2010</xref>; <xref rid="B45" ref-type="bibr">Roni and Rahman, 2017</xref>), adult ADHD (<xref rid="B37" ref-type="bibr">Martin et al., 2018</xref>), anti-depressant (<xref rid="B46" ref-type="bibr">Roni and Rahman, 2015</xref>), anti-epileptic (<xref rid="B63" ref-type="bibr">Tamboli et al., 2012</xref>), and Parkinson&#x02019;s disease (<xref rid="B35" ref-type="bibr">Li et al., 2014</xref>).</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Structure and molecular mechanism of lobeline. <bold>(A)</bold> Chemical structure. <bold>(B, C)</bold> Molecular interaction of lobeline bound to the human &#x003b1;7-nAChR (<xref rid="B54" ref-type="bibr">Spurny et al., 2015</xref>). <bold>(D)</bold> A schematic diagram of the multiple cellular mechanisms of lobeline on the release of norepinephrine taken from the reference (<xref rid="B48" ref-type="bibr">S&#x000e1;ntha et al., 2000</xref>).</p></caption><graphic xlink:href="fphar-12-638210-g001"/></fig><p>For example, in their study, Roni and Rahman noticed that adult C57BL/6J mice when treated with once daily dose of lobeline (1&#x000a0;mg/kg, s.c.) in the last 14&#x000a0;days of their exposure to chronic unpredictable stress (CUS) for 6&#x000a0;weeks produced antidepressant-like effects. They proposed targeting brain nicotinic acetylcholine receptors (nAChRs), brain-derived neurotrophic factor (BDNF) expression and/or cell proliferation in the hippocampus to be the most likely cause of the observed antidepressant-like effects of lobeline (<xref rid="B46" ref-type="bibr">Roni and Rahman, 2015</xref>). Saline was used as the negative control. Hart et al. reported that at doses of 1.0&#x000a0;mg/kg and 3.0&#x000a0;mg/kg subcutaneous injections of lobeline attenuates self-administration of intravenous (i.v.) heroin (3,6 diacetylmorphine HCl) infusions (18&#x000a0;&#x003bc;g/kg) in male Sprague-Dawley rats suggesting their use in pharmacotherapy for opioid abuse (<xref rid="B20" ref-type="bibr">Hart et al., 2010</xref>). In both studies, however, they did not make a comparison of the effect of lobeline with any reference standard.</p><p>Martin et al. reported the results of a preclinical study in which they studied the effect of lobeline in adult ADHD (<xref rid="B37" ref-type="bibr">Martin et al., 2018</xref>). In their study, they subjected a total of nine adults (5 females, 4 males, ages 23&#x02013;41 [31.11 &#x000b1; 7.08&#x000a0;years]) to a 7-day protocol of oral administration of methylphenidate capsule (0, 15, or 30&#x000a0;mg, p.o.) followed by sublingual (s.l.) administration of lobeline tablets (0, 7.5, 15, or 30&#x000a0;mg, s.l.) after 1&#x000a0;h. Inactive doses of both sublingual and oral formulations were used as placebo. They observed that lobeline could improve working memory in a modest capacity (without significant improvement in their attention) in nine volunteers with ADHD.</p><p>Li et al. investigated the effect of s.c administrations of lobeline hydrochloride (1 or 3&#x000a0;mg/kg) on male C57BL/6J mice against methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP, 30&#x000a0;mg/kg)-induced cell death <italic>in vivo</italic> using L-dopa (80&#x000a0;mg/kg) and the potent and selective dopamine reuptake inhibitor, GBR12935 (10&#x000a0;mg/kg) as positive controls (<xref rid="B35" ref-type="bibr">Li et al., 2014</xref>). The s.c. injections of lobeline, GBR12935, or L-dopa were done for 11&#x000a0;days 30&#x000a0;min prior to MPTP administration. They observed that MPTP induced locomotive effects detected in behavioral tests were significantly reduced by lobeline as compared to L-dopa and GBR12935. Further, they observed that the loss of neurotoxin-induced immunoreactivity was significantly reduced in the substantia nigra and striatum regions of the brain. The overall results indicated that lobeline may protect dopaminergic neurons and alleviate the symptoms of Parkinson&#x02019;s disease. Saline was used as the negative control.</p><p>Tamboli et al. investigated lobeline isolated from <italic>Lobelia</italic> nicotianaefolia in chemoconvulsant-induced seizures using diazepam as a reference standard (<xref rid="B63" ref-type="bibr">Tamboli et al., 2012</xref>). The anticonvulsant activity of the isolated lobeline was investigated at 5, 10, 20 and 30&#x000a0;mg/kg, intraperitoneal (i.p.) doses in Pentylenetetrazol (PTZ) and strychnine induced seizures in Swiss albino male mice. They found that isolated lobeline induces potent anticonvulsant activity against PTZ induced seizures by enhancing the brain gamma amino butyric acid (GABA) level at 20&#x000a0;mg/kg i.p. within a duration of 45&#x000a0;min after their administration. Saline was used as the negative control.</p><p>Mechanistically, lobeline was reported binding to the &#x003b1;4&#x003b2;2 nAChR with nanomolar affinity (<xref rid="B7" ref-type="bibr">Brioni et al., 1997</xref>) but with less potent affinity against muscarinic and acetylcholinesterase receptors (<xref rid="B80" ref-type="bibr">Terry et al., 1998</xref>). The high-affinity partial agonist property of lobeline against &#x003b1;4&#x003b2;2 nAChR was later identified as the mechanism for smoking cessation (<xref rid="B71" ref-type="bibr">Wu et al., 2006</xref>; <xref rid="B6" ref-type="bibr">Billen et al., 2012</xref>). Recently, Anitha et al. shed additional light on how smoking cessation by lobeline occurs through trapping in &#x003b1;4&#x003b2;2 receptors-containing acidic vesicles and how intracellular pH homeostasis plays a crucial role in it (<xref rid="B19" ref-type="bibr">Govind et al., 2017</xref>). Lobeline was also demonstrated to block the blood-brain barrier (BBB) basic amine transporter (<xref rid="B2" ref-type="bibr">Allen et al., 2003</xref>), and act as VMAT2 ligand (<xref rid="B77" ref-type="bibr">Zheng et al., 2005</xref>; <xref rid="B76" ref-type="bibr">Zheng et al., 2006</xref>). In another study, (&#x02212;)-lobeline hydrochloride monohydrate (10 or 20&#x000a0;mg/kg, i.p.) was reported to reduce the DNA damage and oxidative stress induced by seizures in a pilocarpine-induced seizure model on 69 adult male CF-1 mice (<xref rid="B12" ref-type="bibr">da Costa E Silva et al., 2018</xref>). The administrations of pilocarpine (300&#x000a0;mg/kg) were performed after 30&#x000a0;min treatment of lobeline, diazepam (positive control) or saline (negative control).</p><p>Overall, to date, more than 610 scientifically peer-reviewed research articles carrying the pharmacological investigation of the pyridine alkaloid lobeline and its structural analogs were reported underlying its medicinal importance. However, the gastrointestinal side effects (due to nicotinic effects), the lethal toxicity due to its narrow therapeutic index, and other adverse side effects such as choking and cough limits the clinical utility of lobeline (<xref rid="B9" ref-type="bibr">Butler et al., 2001</xref>; <xref rid="B44" ref-type="bibr">Raj et al., 2005</xref>; <xref rid="B55" ref-type="bibr">Stead and Hughes, 2012</xref>; <xref rid="B22" ref-type="bibr">Heinzerling, 2013</xref>).</p><sec id="s1-1"><title>Beyond Lobeline: Other Bioactive Alkaloids</title><p>In the early 1950s, the German phytochemist Steinegger and team reported several key discoveries on the identification and pharmacological studies of the newer alkaloids from different <italic>Lobelia</italic> species. First, they reported the identification of a crystallized alkaloid named lurenine isolated from <italic>Lobelia urens</italic> (<xref rid="B57" ref-type="bibr">Steinegger and Grutter, 1950</xref>)<italic>.</italic> Subsequently, they also identified two new alkaloids lophilin and lophilacrin in the alkaloid fraction of <italic>Lobelia siphilitica</italic> (<xref rid="B56" ref-type="bibr">Steinegger and Egger, 1952</xref>). In the 1950s, other studies began to reveal the distinctive pharmacological properties of the alkaloid constituents identified in different <italic>Lobelia</italic> species (<xref rid="B34" ref-type="bibr">Lendle and Richter, 1950</xref>), which has further raised tremendous interest in phytochemical research. Lobinaline 2, the only alkaloid found in the <italic>Lobelia cardinalis</italic> L. and the first binitrogenous alkaloid extracted from any <italic>Lobelia</italic> species was reported having a unique nAChR binding activity (<xref rid="B31" ref-type="bibr">Klosa, 1953</xref>; <xref rid="B27" ref-type="bibr">Kaczmarek and Steinegger, 1958</xref>; <xref rid="B8" ref-type="bibr">Brown et al., 2016</xref>). In addition to their equipotent &#x003b1;4&#x003b2;2-and &#x003b1;7-nAChRs binding profile, the purified lobinaline obtained from CHCl<sub>3</sub> fraction of air-dried aerial portions of <italic>L. cardinalis</italic> also exhibited potent 2,2-Diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging properties, inhibited <italic>in vitro</italic> [(3)H]-dopamine uptake in adult male Sprague-Dawley rats striatal synaptosomes, and potent dopamine transporter inhibition (<ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?nPC87m">Brown et al., 2016</ext-link>). Reportedly, lobinaline (stock solution: 1&#x000a0;mg/ml) scavenge DPPH free radicals with an EC<sub>50</sub> of 17.98&#x000a0;&#x003bc;M when examined in DPPH (stock solution: 600&#x000a0;&#x003bc;M) free radical scavenging assay. In contrast, lobeline (stock solution: 1&#x000a0;mg/ml) demonstrated a weak DPPH free radical scavenging property (EC<sub>50</sub> = 228.8&#x000a0;&#x003bc;M). <italic>In vivo</italic> electrochemical studies indicated that lobinaline in a short acting and likely competitive-capacity inhibits dopamine transporter function in the dorsal striatum of urethane-anesthetized rats. Interestingly, lobinaline (1&#x000a0;mM) was noticed significantly increasing <sup>45</sup>Ca<sup>2+</sup> entry in SH-SY5Y cells.</p><p>In 1954, major alkaloids named lobelanidine 3, and lelobanidine 4 were also isolated from <italic>Lobelia nicotianaefolia</italic> (<xref rid="B17" ref-type="bibr">Gedeon and Gedeon, 1954</xref>). Lobelanidine 3 was subsequently identified in <italic>Lobelia chinensis</italic> exhibiting anticancer and anti-emetic properties (<xref rid="B11" ref-type="bibr">Chen et al., 2014</xref>). In 2001, two new pyrrolidine alkaloids, radicamines A 5 and radicamines B 6 isolated from the hot water extract of <italic>Lobelia chinensis</italic> Lour. (<xref rid="B53" ref-type="bibr">Shibano et al., 2001</xref>). The basic extract solution (25&#x000a0;&#x000b5;L) was were identified exhibiting potent alpha-glucosidase (100&#x000a0;&#x000b5;L) inhibition (<xref rid="B53" ref-type="bibr">Shibano et al., 2001</xref>). Radicamines A, radicamines B and the positive control (2<italic>R</italic>,3<italic>R</italic>,4<italic>R</italic>,5<italic>R</italic>) 2,5-dihydroxymethyl-3,4-dihydroxy-pyrrolidine (DMDP) exhibited IC<sub>50</sub> of 6.7 &#x000d7; 10<sup>&#x02013;6</sup>, 9.3 &#x000d7; 10<sup>&#x02013;6</sup>, and 4.9 &#x000d7; 10<sup>&#x02013;6</sup>&#x000a0;M, respectively.</p><p>In 2015, Paz et al. reported a new alkaloid, pentylsedinine 7, isolated from the fresh aerial parts of <italic>Lobelia tupa</italic> (<xref rid="B42" ref-type="bibr">Paz et al., 2015</xref>). When evaluated against the &#x003b1;3&#x003b2;2/&#x003b1;3&#x003b2;4 nAChR and &#x003b1;7 nAChR receptors expressed in the human neuroblastoma cell line SH-SY5Y, like lobeline, (-)-pentylsedinine acted as a non-selective partial agonist at homomeric &#x003b1;7 nAChR (EC<sub>5</sub>0 0.4 &#x000b1; 0.08&#x000a0;&#x000b5;M) and heteromultimeric &#x003b1;3&#x003b2;2/&#x003b1;3&#x003b2;4 (EC<sub>50</sub> 0.33 &#x000b1; 0.07&#x000a0;&#x000b5;M) nAChR. Interestingly, the co-addition of lobeline and (-)-pentylsedinine desensitized &#x003b1;7 nAChR to the response from the selective &#x003b1;7 nAChR agonist choline. Apparent IC<sub>50</sub> of lobeline and (-)-pentylsedinine were 1.6 &#x000b1; 0.4&#x000a0;&#x000b5;M and 0.37 &#x000b1; 0.08&#x000a0;&#x000b5;M, respectively.</p><p>Lobelane 8, a defunctionalized analog of lobeline exhibited 10&#x02013;15 fold more potent effects than lobeline in inhibition of the vesicular dopamine (DA) uptake by VMAT2, and inhibited (+)-methamphetamine-evoked DA release (<xref rid="B66" ref-type="bibr">Vartak et al., 2009</xref>; <xref rid="B41" ref-type="bibr">Nickell et al., 2010</xref>). It was also reported to possess a fivefold binding affinity than lobeline for the dihydrotetrabenazine binding site on VMAT2 (<xref rid="B39" ref-type="bibr">Miller et al., 2004</xref>; <xref rid="B77" ref-type="bibr">Zheng et al., 2005</xref>). In a study aimed at synthesizing lobelane analogs as therapeutic agents, replacement of the phenyl groups of lobelane with quinolyl groups resulted in a water-soluble analog called quinlobelane nine that possessed stronger VMAT2 inhibition (<xref rid="B65" ref-type="bibr">Vartak et al., 2010</xref>).</p><p>The phytochemical research conducted over the years suggested that alkaloids are the predominant secondary metabolites (&#x0223c;46%) present in most of the <italic>Lobelia</italic> species known. These alkaloids ubiquitously contain <italic>N</italic>-methylpiperidine ring or piperidine ring along with one or two substituents at the C<sub>2</sub> and/or C<sub>6</sub> position of the ring (<xref rid="B14" ref-type="bibr">Felpin and Lebreton, 2004</xref>; <xref rid="B15" ref-type="bibr">Folquitto et al., 2019</xref>).</p><p>One of the major disadvantages of the alkaloids derived from the <italic>Lobelia</italic> species has been their extreme resemblance in the chemical structures to each other, essentially sharing similar pharmacological, physicochemical, and toxicological profiles which also include cardiotoxicity (<xref ref-type="fig" rid="F2">Figure 2</xref>). The alkaloids in most of the species of <italic>Lobelia</italic> (with lobeline being the most cited in the literature) are broadly known for presenting medicinal properties against drug abuse, neurological disorder, and respiratory stimulant. The limited medicinal properties of these alkaloids can be attributed to their binding properties at the nAChR receptors. In this present manuscript, we have only considered the publications where the alkaloid was biologically tested. Unfortunately, the bioactivity characterization of a large majority of those alkaloids was not yet reported and thus excluded. Moreover, to date, more than 80 alkaloids are known to be isolated from different species of <italic>Lobelia.</italic> The readers are recommended to the following review for the updates on other isolated alkaloids (<xref rid="B15" ref-type="bibr">Folquitto et al., 2019</xref>).</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Chemical structures of the bioactive alkaloids derived from <italic>Lobelia</italic> species.</p></caption><graphic xlink:href="fphar-12-638210-g002"/></fig></sec><sec id="s1-2"><title>Beyond Alkaloids: The Bioactive Components of Other Classes</title><p>Over the years, the isolation and characterization of secondary metabolites derived from <italic>Lobelia</italic> species have garnered significant attention. It is now an established fact that most species of the genus <italic>Lobelia</italic> contain different classes of secondary metabolites including but not limited to flavonoids, terpenoids, fatty acids, polyacetylenes, coumarins, neolignans, polysaccharides, and amides in varying concentrations. In recent years, the identifications of these newer compounds also presented the opportunities to address the limited bioactivity of alkaloids mentioned earlier. Due to this fact, growing numbers of literature are being published. In this section, we will present a current account of these newer novel bioactive natural products derived from <italic>Lobelia</italic> species. A special focus has been given to accounting for the molecular mechanism of these newer secondary metabolites.</p><p>Since mid-to end- 20th-century investigations into the pharmacology of components derived from <italic>Lobelia</italic> species were centered onto the alkaloids. In 1961, Sasaki et al. reported the isolation of a new glucofructan &#x0201c;sessilifolan&#x0201d; from <italic>Lobelia sessilifolia</italic> Lamb. I. (<xref rid="B51" ref-type="bibr">Sasaki et al., 1961</xref>; <xref rid="B50" ref-type="bibr">Sasaki and Mikami, 1962</xref>). It was perhaps the first report identifying other secondary metabolites than alkaloids in <italic>Lobelia</italic>. In 1986, Santosa et al. reported the <italic>in vitro</italic> as well as <italic>in vivo</italic> activity of the hot water extract of <italic>Lobelia chinensis</italic> against Ehrlich ascites tumor and Sarcoma 180&#x000a0;cells (<xref rid="B49" ref-type="bibr">Santosa et al., 1986</xref>). However, in subsequent decades, not much progress has been made on characterizing the other classes of secondary metabolites.</p><p>Subarnas et al. identified a novel antidepressant bioactive component, &#x003b2;-amyrin palmitate 10 in an extract of the leaves of <italic>Lobelia inflata</italic> (<xref rid="B59" ref-type="bibr">Subarnas et al., 1992</xref>). Further studies indicated that the antidepressant activity of &#x003b2;-amyrin palmitate 10 was related to the activation of the noradrenergic system by releasing [3H]norepinephrine from newly synthesized pools, with mianserin-like action (<xref rid="B61" ref-type="bibr">Subarnas et al., 1993b</xref>; <xref rid="B62" ref-type="bibr">Subarnas et al., 1993c</xref>). In a forced swimming test, &#x003b2;-amyrin palmitate at 10&#x000a0;mg/kg reduced the tetrabenazine-induced (100 and 200&#x000a0;mg/kg) increase in the duration of the immobility of mice whereas it has shown no effect when treated with alpha-methyl-para-tyrosine (500&#x000a0;mg/kg). Similarly, at 5 and 10&#x000a0;mg/kg, it has decreased the duration of immobility in mice treated with 6-hydroxy-dopamine (50&#x000a0;&#x000b5;g/mouse) and desipramine (15&#x000a0;mg/kg) without showing any effect to the treatment of mice with nomifensine plus 6-hydroxydopamine (<xref rid="B61" ref-type="bibr">Subarnas et al., 1993b</xref>). Physicochemically, beta-amyrin palmitate is a water-insoluble, extremely weak basic compound belonging to the triterpenoids compound class which contains six isoprene units. Other studies reported &#x003b2;-amyrin palmitate exhibiting different pharmacological properties such as induction of hypoactivity by inhibiting alpha 1-adrenoceptors (<xref rid="B60" ref-type="bibr">Subarnas et al., 1993a</xref>), anti-diabetic and anti-hyperglycemic activity by blocking the entry of glucose from the intestine (<xref rid="B40" ref-type="bibr">Nair et al., 2014</xref>), and antibacterial against Gram-positive and negative bacteria and antifungal activities (<xref rid="B1" ref-type="bibr">Abed et al., 2016</xref>).</p><p>Recently, Wang et al. reported the identification of four novel flavonoid glycosides, lobelitin A-D 11&#x02013;14 exhibiting agonistic activities against G protein-coupled receptor 35 (GPR35) (<xref rid="B67" ref-type="bibr">Wang et al., 2019</xref>). The compounds were isolated from <italic>Lobelia chinensis</italic>.</p><p>The authors noticed that lobelitin A-D triggers dose-dependent positive signals (monitored for 1&#x000a0;h) in dynamic mass redistribution (DMR) agonist assay in varying concentration. For example, at 200&#x000a0;pm, lobelitin A, B, and D were recorded exhibiting the largest DMR signal whereas at about 100&#x000a0;pm, lobelitin C exhibited a weaker signal at the maximum concentration of 250&#x000a0;&#x000b5;M. Based on these results, the authors suggested lobelitin A, B and D as the full agonist and lobelitin C as a partial agonist of GPR35. The structures and the apparent EC<sub>50</sub> and IC<sub>50</sub> values of lobelitin A-D are shown in <xref ref-type="fig" rid="F3">Figure 3</xref> and <xref rid="T1" ref-type="table">Table 1</xref>. GPR35 has been implicated in several diseased conditions including hypertension, coronary artery disease, and cancer, and is an area of active research (<xref rid="B13" ref-type="bibr">Divorty et al., 2015</xref>; <xref rid="B68" ref-type="bibr">Wei et al., 2017</xref>; <xref rid="B43" ref-type="bibr">Quon et al., 2020</xref>).</p><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>Chemical structures of non-alkaloids novel bioactive compounds isolated from <italic>Lobelia</italic> species.</p></caption><graphic xlink:href="fphar-12-638210-g003"/></fig><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p>Pharmacological characteristics of active flavonoid glycosides derived from <italic>Lobelia chinensis</italic> in HT-29 cells (<xref rid="B67" ref-type="bibr">Wang et al., 2019</xref>).</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="center" rowspan="1" colspan="1">Compounds</th><th align="center" rowspan="1" colspan="1">EC<sub>50</sub> (&#x000b5;M)</th><th align="center" rowspan="1" colspan="1">IC<sub>50</sub>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref> (&#x000b5;M)</th><th align="center" rowspan="1" colspan="1">IC<sub>50</sub>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref> (&#x000b5;M)</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Lobelitin A</td><td align="char" char="plusmn" rowspan="1" colspan="1">49.92 &#x000b1; 12.61</td><td align="char" char="plusmn" rowspan="1" colspan="1">0.38 &#x000b1; 0.08</td><td align="char" char="plusmn" rowspan="1" colspan="1">47.63 &#x000b1; 6.31</td></tr><tr><td align="left" rowspan="1" colspan="1">Lobelitin B</td><td align="char" char="plusmn" rowspan="1" colspan="1">18.77 &#x000b1; 2.02</td><td align="char" char="plusmn" rowspan="1" colspan="1">0.27 &#x000b1; 0.03</td><td align="char" char="plusmn" rowspan="1" colspan="1">27.89 &#x000b1; 2.33</td></tr><tr><td align="left" rowspan="1" colspan="1">Lobelitin C</td><td align="center" rowspan="1" colspan="1">Weak</td><td align="char" char="plusmn" rowspan="1" colspan="1">0.39 &#x000b1; 0.21</td><td align="char" char="plusmn" rowspan="1" colspan="1">72.74 &#x000b1; 22.96</td></tr><tr><td align="left" rowspan="1" colspan="1">Lobelitin D</td><td align="char" char="plusmn" rowspan="1" colspan="1">67.65 &#x000b1; 37.99</td><td align="char" char="plusmn" rowspan="1" colspan="1">0.48 &#x000b1; 0.13</td><td align="char" char="plusmn" rowspan="1" colspan="1">64.70 &#x000b1; 17.19</td></tr></tbody></table><table-wrap-foot><fn id="Tfn1"><label><sup>a</sup></label><p>IC<sub>50</sub> of ML145 to block the DMR of compounds.</p></fn><fn id="Tfn2"><label><sup>b</sup></label><p>IC<sub>50</sub> to desensitize the DMR of 1&#x000a0;&#x000b5;M zaprinast in HT-29 cells.</p></fn></table-wrap-foot></table-wrap><p>The glucoside 2,6-Dideoxy-7-O-(b- D -glucopyranosyl) 2,6-imino- D -glycero- L -gulo-heptitol (7-O-&#x003b2;-D-glucopyranosyl-&#x003b1;-homonojir-imycin, 15) isolated from the methanol extract of the whole plant of <italic>Lobelia sessilifolia</italic> exhibited potent inhibitory activity against various &#x003b1;-glucosidases (<xref rid="B24" ref-type="bibr">Ikeda et al., 2000</xref>). Specifically, 7-<italic>O</italic>-&#x003b2;- D -glucopyranosyl-&#x003b1;-homonojir-imycin exhibited an IC<sub>50</sub> of 0.25and 0.27&#x000a0;&#x000b5;M against rice and rat intestinal isomaltase &#x003b1;-glucosidase, respectively. Additionally, it has also shown the inhibition of porcine kidney trehalase (IC<sub>50</sub> = 0.013&#x000a0;&#x000b5;M) and anti-diabetic property (<xref rid="B24" ref-type="bibr">Ikeda et al., 2000</xref>).</p><p>Kuo et al. reported the antivirus and anti-inflammatory properties of a novel compound lobechine 16 alongwith scoparone (6,7-dimethoxycoumarin) 17 isolated from the methanol extracts of <italic>Lobelia chinensis</italic>. Lobechine 16 inhibited elastase release with IC<sub>50</sub> of 25.01 &#x000b1; 6.95&#x000a0;&#x003bc;M whereas scoparone 17 inhibited superoxide anion generation with IC<sub>50</sub> of 6.14 &#x000b1; 1.97&#x000a0;&#x003bc;M (<xref rid="B32" ref-type="bibr">Kuo et al., 2011</xref>).</p><p>A neutral polysaccharide (LCPS) 18 was isolated from <italic>Lobelia chinensis</italic> lour. The monosaccharide composition of LCPS was observed as fructan composed of 2,1-linked-&#x003b2;-D-fructofuranosyl residue and &#x003b1;-D-glu-copyranosyl residue with &#x003b1;-D-Glcp-(1&#x02192;[1)-&#x003b2;-D-Fruf-(2]<sub>15</sub> glycosidic linkage. LCPS was identified as an inulin-type fructan with 2.6&#x000a0;kDa molecular weight with an effective therapeutic option in the treatment of obesity. Oral administration of this inulin alleviated obesity and reduced body weight in high-fat diet-induced mice (<xref rid="B75" ref-type="bibr">Zhang et al., 2020</xref>). Specifically, the anti-obesity effects of LCPS evaluated <italic>in vivo</italic> in male Kunming mice treated with normal chow diet (D12450 J), high fat diet (D12492) and high fat diet plus LCPS (300&#x000a0;mg/kg/day) for eight weeks showed 67% lower body weight gain as compared to high fat diet treatment. High fat diet plus glibenclamide (5&#x000a0;mg/kg/day) was used as a positive control which has shown 77% effect.</p><p>Li et al. isolated another neutral &#x003b1;-glucan, named BP1 19 (Mol. weight: 9.45&#x000a0;kDa), from <italic>Lobelia chinensis</italic> by hot-water extraction and studied its immunomodulating activities (<xref rid="B36" ref-type="bibr">Li et al., 2016</xref>). The authors proposed that &#x003b1;-glucan BP1 activates Toll-like receptor 4 (TLR4) and exerts immunomodulating effects such as enhancement of the cell proliferation, nitric oxide production, cytokine secretion and phagocytosis in a dose-dependent manner. Additionally, the glucan also induced cytokine and nitric oxide production mediated by toll-like receptor 4 (TLR4) in RAW 264.7 cells. The backbone of BP1 consisted of alternating units of <sub>6</sub>&#x003b1;- D -Glcp<sup>1</sup> -- <sub>6,3</sub>&#x003b1;- D -Glcp<sup>1</sup>-- (<sub>6</sub>&#x003b1;- D-Glcp<sup>1</sup>)x--(<sub>6,3</sub>&#x003b1;- D -Glcp<sup>1</sup>)y. The side chains were &#x003b1;-D-Glcp<sup>1</sup> --(<sub>6</sub>&#x003b1;-D-Glcp<sup>1</sup>)z--<sub>4</sub>&#x003b1;-D-Glcp<sup>1</sup>--<sub>3</sub>&#x003b1;-D-Glcp<sup>1</sup>--<sub>4</sub>&#x003b1;-D-Glcp<sup>1</sup> and &#x003b1;- D-Glcp<sup>1</sup> terminally attached to backbone O-3 of <sub>6,3</sub>&#x003b1;- D -Glcp<sup>1</sup> (as shown in <xref ref-type="fig" rid="F4">Figure 4</xref>). Specifically, BP1 demonstrated a dose-dependent induction of proliferation of RAW 264.7&#x000a0;cells at the concentrations of 12.5, 25, 50, and 100&#x000a0;&#x000b5;g/ml when administered together with polyB in an MTT assay and tested for 24&#x000a0;h.</p><fig id="F4" position="float"><label>FIGURE 4</label><caption><p>Chemical diversity of the components derived from 17 <italic>Lobelia</italic> species. <bold>(A)</bold>. The distribution of the chemical compounds in the top 10 clusters based on ECFP4 fingerprint. <bold>(B)</bold>. Chemical structure of the representative compound in individual clusters (<xref rid="B78" ref-type="bibr">Zheng et al., 2020</xref>).</p></caption><graphic xlink:href="fphar-12-638210-g004"/></fig><p>Ishimaru et al., isolated two new polyacetylene compounds lobetyolin 20 and lobetyol 21 from the hairy roots of <italic>Lobelia inflata</italic> (<xref rid="B25" ref-type="bibr">Ishimaru et al., 1991</xref>)<italic>.</italic> Recently, He et al. studied the effect of lobetyolin on colorectal cancer (<xref rid="B21" ref-type="bibr">He et al., 2020</xref>). They found that lobetyolin induces colon cancer cells by inhibiting the ASCT2-mediated glutamine metabolism. Briefly, they have incubated lobetyolin in HCT&#x02010;116&#x000a0;cells for 3, 6, 12, 18 and 24&#x000a0;h at varying concentrations of 10, 20 and 40&#x000a0;&#x003bc;mol/L in an MTT assay and observed that lobetyolin induces largest inhibitory effect on survival rate at 24&#x000a0;h. On the other hand, the authors did not observe any significant influence in the cell viability in NCM460 cells at 10, 20 and 40&#x000a0;&#x003bc;mol/L. Additionally, they observed that lobetyolin at 10, 20, and 40&#x000a0;&#x003bc;mol/L prominently suppresses the expression of ASCT2 protein and reduces the mRNA levels. In addition, lobetyolin at 40&#x000a0;&#x003bc;mol/L also inhibited the expression of ASCT2 in HCT-116 cells. Further, lobetyolin (10, 20, and 40&#x000a0;mg/kg) inhibited the tumor volume in the nude (nu/nu) mice transplanted with HCT&#x02010;116 cells. In another study, Shen et al. reported that lobetyol induces anti-carcinoma effect in MKN45 cells and activates MAPK pathways associated with G<sub>1</sub>/S cell cycle arrest in a time- and dose-dependent manner (<xref rid="B52" ref-type="bibr">Shen et al., 2016</xref>). Specifically, the anti-proliferative effect of lobetyol in MKN45 cells was evaluated in an MTT assay at a varying concentration and time ranging from 50&#x000a0;&#x000b5;g/ml, 75&#x000a0;&#x000b5;g/ml, to 110&#x000a0;&#x000b5;g/ml and 12&#x000a0;h, 24&#x000a0;h, to 48&#x000a0;h, respectively. Lobetyol demonstrated an IC<sub>50</sub> of 71.47 &#x000b1; 4.29&#x000a0;&#x000b5;g/ml at 48&#x000a0;h. Further, in MKN45 cells, an increasing dose of lobetyol ranging from 0, 50, and 75&#x000a0;&#x000b5;g/ml, to 110&#x000a0;&#x000b5;g/ml led to an increase in apoptotic population by 5.5%, 13.74%, 27.32%&#x02013;31.57%, respectively.</p><p>Two other polyacetylene isolobetyol 22 and lobetyol 21 isolated from <italic>Lobelia chinensis</italic> exhibited moderate cytotoxic activities against MSTO-211H and NCI-H292 cell lines (treated for 48&#x000a0;h). Isolobetyol exhibited the IC<sub>50</sub> values of 12.36 and 9.31&#x000a0;&#x003bc;M against the two cell lines; while the lobetyol showed the IC<sub>50</sub> values of 11.76 and 9.64&#x000a0;&#x003bc;M, respectively (<xref rid="B72" ref-type="bibr">Yang et al., 2014</xref>). In contrast, positive control (cisplatin) showed an IC<sub>50</sub> of 4.91 and 7.89&#x000a0;&#x003bc;M against MSTO-211H and NCI-H292 cell lines, respectively. However, the authors did not mention at which concentrations the compounds were tested.</p><p>In another report, Joshi et al. analyzed the essential oil composition of the aerial parts of <italic>Lobelia pyramidalis</italic> Wall and evaluated their antimicrobial activity (<xref rid="B26" ref-type="bibr">Joshi et al., 2011</xref>). Serial doubling dilutions of the essential oil were prepared from 0.10 to 200&#x000a0;mg/ml and incubated in Mueller Hinton broth for the bacterial strains at 37&#x000b0;C for 24&#x000a0;h. The minimal inhibitory concentration and inhibition zone of 3.12&#x000a0;mg/ml and 18&#x000a0;mm, respectively was determined against the bacterial strain <italic>S. aureus</italic>. The authors suggested natural terpenoid perilla ketone could be the responsible chemical constituent. However, no further attempt was made to isolate and characterize the compound.</p><p>In a recent study, Ma and colleagues identified 208 metabolites of <italic>Lobelia chinensis</italic> by gas chromatography-mass spectrometer (GC/MS) and conducted a network pharmacology-based investigation of their anti-diabetic mechanism (<xref rid="B16" ref-type="bibr">Ge et al., 2020</xref>). Their study revealed that 5-hydroxymethylfurfural 23 acts on GSK3B, TNF, and MAPK1 and affects the insulin resistance signaling pathway as the major mechanism of action. Also, acacetin might act on INSR, DPP4, and GSK3B. No biological evaluation was performed to validate the network pharmacology approach&#x02019;s presented findings, which remains one major drawback of this work.</p><p>We have also recently investigated the neuroprotection mechanism of the pharmacokinetically favorable, experimentally validated active compounds derived from the 17 <italic>Lobelia</italic> species (<xref rid="T2" ref-type="table">Table 2</xref>) based on network pharmacology and molecular modeling (<xref rid="B78" ref-type="bibr">Zheng et al., 2020</xref>). In this work, we also studied the chemical diversity of the validated natural compounds identified in the genus of the <italic>Lobelia</italic> species including the major components of <italic>Lobelia chinensis</italic> studied by Ma and Colleagues (<xref rid="B16" ref-type="bibr">Ge et al., 2020</xref>). Fascinatingly, the aglycone part of the flavonoid such as diosmetin and 18 other aglycones constituted the densest cluster indicating their profound presence in the <italic>Lobelia</italic> species. The representative chemical structure of the top 10 clusters is shown in <xref ref-type="fig" rid="F4">Figure 4B</xref>. We have also not performed the biological evaluations. However, in this review, we intended to summarize the experimentally determined chemical constituents of <italic>Lobelia</italic> and draw a comparison in their chemical structures (as shown in <xref ref-type="fig" rid="F4">Figure 4</xref>).</p><table-wrap id="T2" position="float"><label>TABLE 2</label><caption><p>
<italic>Lobelia</italic> species used in our study to investigate the neuroprotection mechanism.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">NPASS IDs</th><th align="center" rowspan="1" colspan="1">Herb name</th><th align="center" rowspan="1" colspan="1">Family</th><th align="center" rowspan="1" colspan="1">Super kingdom</th><th align="center" rowspan="1" colspan="1"># Of natural product</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">NPO10220</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia davidii</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">
<xref rid="B74" ref-type="bibr">Zhang et al. (1990)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NPO11547</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia cardinalis</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">
<xref rid="B27" ref-type="bibr">Kaczmarek and Steinegger (1958)</xref>, <xref rid="B29" ref-type="bibr">Kelley et al. (2019)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NPO11565</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia salicifolia</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">
<xref rid="B58" ref-type="bibr">Steinegger and Ochsner (1956)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NPO14650</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia chinensis</italic>
<xref ref-type="table-fn" rid="Tfn3">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">
<xref rid="B53" ref-type="bibr">Shibano et al. (2001)</xref>, <xref rid="B79" ref-type="bibr">Zhou et al. (2008)</xref>, <xref rid="B32" ref-type="bibr">Kuo et al. (2011)</xref>, <xref rid="B72" ref-type="bibr">Yang et al. (2014)</xref>, <xref rid="B36" ref-type="bibr">Li et al. (2016)</xref>, <xref rid="B67" ref-type="bibr">Wang et al. (2019)</xref>, <xref rid="B32" ref-type="bibr">Kuo et al. (2011)</xref>, <xref rid="B16" ref-type="bibr">Ge et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NPO14996</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia syphilitica</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">
<xref rid="B30" ref-type="bibr">Kesting et al. (2009)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NPO15709</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia langeana</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NPO16059</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia polyphylla</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">
<xref rid="B69" ref-type="bibr">Weinges et al. (1972)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NPO17414</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia portoricensis</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">
<xref rid="B38" ref-type="bibr">Mel&#x000e9;ndez et al. (1967)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NPO18202</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia radicans</italic>
<xref ref-type="table-fn" rid="Tfn3">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NPO238</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia st</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NPO24373</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia inflata</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">
<xref rid="B25" ref-type="bibr">Ishimaru et al. (1991)</xref>, <xref rid="B4" ref-type="bibr">B&#x000e1;lv&#x000e1;nyos et al. (2004)</xref>, <xref rid="B33" ref-type="bibr">Kursinszki et al. (2008)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NPO26111</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia camporum</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NPO293</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia nicotianifolia</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NPO29542</td><td align="left" rowspan="1" colspan="1">
<italic>Lobeliae chinensis herba</italic>
<xref ref-type="table-fn" rid="Tfn3">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NPO28802</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia nummularia</italic> lam</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">
<xref rid="B25" ref-type="bibr">Ishimaru et al. (1991)</xref>, <xref rid="B23" ref-type="bibr">Ho et al. (1995)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NPO5012</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia hassleri</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NPO5051</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia urens</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NPO5103</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia berlandieri</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">
<xref rid="B70" ref-type="bibr">Williams et al. (1987)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NPO615</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia exaltata</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NPO8894</td><td align="left" rowspan="1" colspan="1">
<italic>Lobelia fistulosa</italic>
</td><td align="center" rowspan="1" colspan="1">Campanulaceae</td><td align="center" rowspan="1" colspan="1">Eukaryota</td><td align="char" char="." rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="Tfn3"><label><sup>a</sup></label><p>are the same species with two different entries in NPASS database. (<xref rid="B73" ref-type="bibr">Zeng et al., 2018</xref>)</p></fn></table-wrap-foot></table-wrap></sec><sec id="s1-3"><title>Data Sources and Study Selection</title><p>The literature search was performed using PubMed and Scifinder over the period from the beginning of the database until October 2020. Initially, all the literature associated with the search term &#x0201c;<italic>Lobelia</italic>&#x0201d; were collected. In addition, the databases were also directly searched using the botanical name (e.g., &#x0201c;<italic>Lobelia chinensis</italic>&#x0201d;). In addition, as a third search strategy, the databases of the major research journals including Science Direct, Frontiers, Wiley, American Chemical Society, MDPI, Springer-Nature, and Taylor and Francis were also searched manually. Articles that have reported only isolation and identification of chemical constituents without biological activities were excluded. No unpublished literature data or conference proceedings were included. Except for a recent systematic review by Folquitto et al. (<xref rid="B15" ref-type="bibr">Folquitto et al., 2019</xref>), other articles that described reviews or systematic reviews were excluded. The systematic review by Folquitto et al. was used as an additional strategy to validate the references for the phytochemical details.</p></sec></sec><sec sec-type="conclusion" id="s2"><title>Conclusion</title><p>Undoubtedly, <italic>Lobelia</italic> is an important genus with profound medicinal value. A lot of work has already been done in understanding the pharmacological role of the alkaloids derived from different <italic>Lobelia</italic> species. Yet, growing investigations on the newer chemical classes indicate that there is certainly an untapped opportunity to obtain bioactive compounds with diverse chemical and pharmacological properties. In this work, we tried to provide the readers the most up-to-date account of the progress made so far, especially toward understanding the molecular mechanism and pharmacological characterizations of the novel bioactive components. Considering the progress being made in the last few years, we believe that this is a timely review to provide the scientific basis for future research aimed at studying the therapeutic potential of the newer chemical compounds derived from the <italic>Lobelia</italic> species.</p></sec></body><back><sec id="s3"><title>Author Contributions</title><p>QZ developed the idea and the review framework, and wrote the first draft of the manuscript. YW surveyed the literature, collected and validated the data. SZ provided the supervision of the overall work, and did the final editing. All authors contributed to corrections and editing of the subsequent revisions. All authors approve and agree with the content.</p></sec><sec id="s4"><title>Funding</title><p>This work was supported by the Program of Survey and Monitoring of Chinese Medicines for National Drugs (No. (2017) 66), Research and Innovation Team of Department of Laboratory Medicine, Hunan University of Medicine (No. 2019-48).</p></sec><sec sec-type="COI-statement" id="s5"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abed</surname><given-names>S. A.</given-names></name><name><surname>Sirat</surname><given-names>H. M.</given-names></name><name><surname>Taher</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Tyrosinase inhibition, anti-acetylcholinesterase, and antimicrobial activities of the phytochemicals from Gynotroches axillaris blume</article-title>. <source>Pak. J. Pharm. Sci.</source>
<volume>29</volume>, <fpage>2071</fpage>&#x02013;<lpage>2078</lpage>. <pub-id pub-id-type="pmid">28375126</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allen</surname><given-names>D. D.</given-names></name><name><surname>Lockman</surname><given-names>P. R.</given-names></name><name><surname>Roder</surname><given-names>K. E.</given-names></name><name><surname>Dwoskin</surname><given-names>L. P.</given-names></name><name><surname>Crooks</surname><given-names>P. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Active transport of high-affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter</article-title>. <source>J. Pharmacol. Exp. Ther.</source>
<volume>304</volume>, <fpage>1268</fpage>&#x02013;<lpage>1274</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.102.045856</pub-id>
<pub-id pub-id-type="pmid">12604705</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andrew</surname><given-names>J.</given-names></name></person-group> (<year>1828</year>). <article-title>Observations on the use of the <italic>Lobelia</italic> inflata, in asthma and other spasmodic diseases</article-title>. <source>Glasg. Med. J.</source>
<volume>1</volume>, <fpage>177</fpage>&#x02013;<lpage>179</lpage>. </mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>B&#x000e1;lv&#x000e1;nyos</surname><given-names>I.</given-names></name><name><surname>Kursinszki</surname><given-names>L.</given-names></name><name><surname>B&#x000e1;nyai</surname><given-names>P.</given-names></name><name><surname>Sz&#x000f6;ke</surname><given-names>&#x000c9;.</given-names></name></person-group> (<year>2004</year>). <article-title>Analysis of polyacetylenes by HPLC in hairy root cultures of <italic>Lobelia</italic> inflata cultivated in bioreactor</article-title>. <source>Chromatographia</source>
<volume>60</volume>, <fpage>S235</fpage>&#x02013;<lpage>S238</lpage>. <pub-id pub-id-type="doi">10.1365/s10337-004-0188-x</pub-id>
</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bell</surname><given-names>R. L.</given-names></name><name><surname>Eiler</surname><given-names>B. J.</given-names></name><name><surname>Cook</surname><given-names>J. B.</given-names></name><name><surname>Rahman</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Nicotinic receptor ligands reduce ethanol intake by high alcohol-drinking HAD-2 rats</article-title>. <source>Alcohol</source>
<volume>43</volume>, <fpage>581</fpage>&#x02013;<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1016/j.alcohol.2009.09.027</pub-id>
<pub-id pub-id-type="pmid">20004336</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Billen</surname><given-names>B.</given-names></name><name><surname>Spurny</surname><given-names>R.</given-names></name><name><surname>Brams</surname><given-names>M.</given-names></name><name><surname>van Elk</surname><given-names>R.</given-names></name><name><surname>Valera-Kummer</surname><given-names>S.</given-names></name><name><surname>Yakel</surname><given-names>J. L.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Molecular actions of smoking cessation drugs at &#x003b1;4&#x003b2;2 nicotinic receptors defined in crystal structures of a homologous binding protein</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>
<volume>109</volume>, <fpage>9173</fpage>&#x02013;<lpage>9178</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1116397109</pub-id>
<pub-id pub-id-type="pmid">22619328</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brioni</surname><given-names>J. D.</given-names></name><name><surname>Decker</surname><given-names>M. W.</given-names></name><name><surname>Sullivan</surname><given-names>J. P.</given-names></name><name><surname>Arneric</surname><given-names>S. P.</given-names></name></person-group> (<year>1997</year>). <article-title>The pharmacology of (-)-nicotine and novel cholinergic channel modulators</article-title>. <source>Adv. Pharmacol.</source>
<volume>37</volume>, <fpage>153</fpage>&#x02013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/s1054-3589(08)60950-3</pub-id>
<pub-id pub-id-type="pmid">8891102</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>D. P.</given-names></name><name><surname>Rogers</surname><given-names>D. T.</given-names></name><name><surname>Pomerleau</surname><given-names>F.</given-names></name><name><surname>Siripurapu</surname><given-names>K. B.</given-names></name><name><surname>Kulshrestha</surname><given-names>M.</given-names></name><name><surname>Gerhardt</surname><given-names>G. A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Novel multifunctional pharmacology of lobinaline, the major alkaloid from <italic>Lobelia</italic> cardinalis</article-title>. <source>Fitoterapia</source>
<volume>111</volume>, <fpage>109</fpage>&#x02013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.fitote.2016.04.013</pub-id>
<pub-id pub-id-type="pmid">27105955</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Butler</surname><given-names>J. E.</given-names></name><name><surname>Anand</surname><given-names>A.</given-names></name><name><surname>Crawford</surname><given-names>M. R.</given-names></name><name><surname>Glanville</surname><given-names>A. R.</given-names></name><name><surname>McKenzie</surname><given-names>D. K.</given-names></name><name><surname>Paintal</surname><given-names>A. S.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Changes in respiratory sensations induced by lobeline after human bilateral lung transplantation</article-title>. <source>J. Physiol.</source>
<volume>534</volume>, <fpage>583</fpage>&#x02013;<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.2001.00583.x</pub-id>
<pub-id pub-id-type="pmid">11454974</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Charlier</surname><given-names>R.</given-names></name><name><surname>Tondeur</surname><given-names>R.</given-names></name></person-group> (<year>1950</year>). <article-title>[Extraction and pharmacological study of <italic>Lobelia</italic> suavibracteata (Haumann) alkaloids]</article-title>. <source>Arch. Int. Pharmacodyn. Ther.</source>
<volume>83</volume>, <fpage>193</fpage>&#x02013;<lpage>195</lpage>. <pub-id pub-id-type="pmid">15426383</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>M. W.</given-names></name><name><surname>Chen</surname><given-names>W. R.</given-names></name><name><surname>Zhang</surname><given-names>J. M.</given-names></name><name><surname>Long</surname><given-names>X. Y.</given-names></name><name><surname>Wang</surname><given-names>Y. T.</given-names></name></person-group> (<year>2014</year>). <article-title>
<italic>Lobelia</italic> chinensis: chemical constituents and anticancer activity perspective</article-title>. <source>Chin. J. Nat. Med.</source>
<volume>12</volume>, <fpage>103</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/S1875-5364(14)60016-9</pub-id>
<pub-id pub-id-type="pmid">24636059</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>da Costa E Silva</surname><given-names>L. D.</given-names></name><name><surname>Pereira</surname><given-names>P.</given-names></name><name><surname>Regner</surname><given-names>G. G.</given-names></name><name><surname>Boaretto</surname><given-names>F. B. M.</given-names></name><name><surname>Hoffmann</surname><given-names>C.</given-names></name><name><surname>Pfl&#x000fc;ger</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>DNA damage and oxidative stress induced by seizures are decreased by anticonvulsant and neuroprotective effects of lobeline, a candidate to treat alcoholism</article-title>. <source>Metab. Brain Dis.</source>
<volume>33</volume>, <fpage>53</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-017-0130-1</pub-id>
<pub-id pub-id-type="pmid">29032429</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Divorty</surname><given-names>N.</given-names></name><name><surname>Mackenzie</surname><given-names>A. E.</given-names></name><name><surname>Nicklin</surname><given-names>S. A.</given-names></name><name><surname>Milligan</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease</article-title>. <source>Front. Pharmacol.</source>
<volume>6</volume>, <fpage>41</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2015.00041</pub-id>
<pub-id pub-id-type="pmid">25805994</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Felpin</surname><given-names>F.-X.</given-names></name><name><surname>Lebreton</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>History, chemistry and biology of alkaloids from <italic>Lobelia</italic> inflata</article-title>. <source>Tetrahedron</source>
<volume>60</volume>, <fpage>10127</fpage>&#x02013;<lpage>10153</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2004.08.010</pub-id>
</mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Folquitto</surname><given-names>D. G.</given-names></name><name><surname>Swiech</surname><given-names>J. N. D.</given-names></name><name><surname>Pereira</surname><given-names>C. B.</given-names></name><name><surname>Bobek</surname><given-names>V. B.</given-names></name><name><surname>Halila Possagno</surname><given-names>G. C.</given-names></name><name><surname>Farago</surname><given-names>P. V.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Biological activity, phytochemistry and traditional uses of genus <italic>Lobelia</italic> (Campanulaceae): a systematic review</article-title>. <source>Fitoterapia</source>
<volume>134</volume>, <fpage>23</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.fitote.2018.12.021</pub-id>
<pub-id pub-id-type="pmid">30664918</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ge</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Yuan</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Feng</surname><given-names>F.</given-names></name><name><surname>Lv</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Network pharmacology-based dissection of the anti-diabetic mechanism of <italic>Lobelia</italic> chinensis</article-title>. <source>Front. Pharmacol.</source>
<volume>11</volume>. <pub-id pub-id-type="doi">10.3389/fphar.2020.00347</pub-id>
</mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gedeon</surname><given-names>J.</given-names></name><name><surname>Gedeon</surname><given-names>S.</given-names></name></person-group> (<year>1954</year>). <article-title>[Alkaloids of lobella nicotianaefolia heyne]</article-title>. <source>Pharm. Acta Helv.</source>
<volume>29</volume>, <fpage>49</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="pmid">13166510</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Glover</surname><given-names>E. D.</given-names></name><name><surname>Rath</surname><given-names>J. M.</given-names></name><name><surname>Sharma</surname><given-names>E.</given-names></name><name><surname>Glover</surname><given-names>P. N.</given-names></name><name><surname>Laflin</surname><given-names>M.</given-names></name><name><surname>Tonnesen</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>A multicenter phase 3 trial of lobeline sulfate for smoking cessation</article-title>. <source>Am. J. Health Behav.</source>
<volume>34</volume>, <fpage>101</fpage>&#x02013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.5993/ajhb.34.1.12</pub-id>
<pub-id pub-id-type="pmid">19663757</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Govind</surname><given-names>A. P.</given-names></name><name><surname>Vallejo</surname><given-names>Y. F.</given-names></name><name><surname>Stolz</surname><given-names>J. R.</given-names></name><name><surname>Yan</surname><given-names>J. Z.</given-names></name><name><surname>Swanson</surname><given-names>G. T.</given-names></name><name><surname>Green</surname><given-names>W. N.</given-names></name></person-group> (<year>2017</year>). <article-title>Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation</article-title>. <source>Elife</source>
<volume>6</volume>, <fpage>e25651</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.25651</pub-id>
<pub-id pub-id-type="pmid">28718768</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hart</surname><given-names>N.</given-names></name><name><surname>Rocha</surname><given-names>A.</given-names></name><name><surname>Miller</surname><given-names>D. K.</given-names></name><name><surname>Nation</surname><given-names>J. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Dose-dependent attenuation of heroin self-administration with lobeline</article-title>. <source>J. Psychopharmacol.</source>
<volume>24</volume>, <fpage>51</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1177/0269881108092119</pub-id>
</mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>W.</given-names></name><name><surname>Tao</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Jie</surname><given-names>Q.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Lobetyolin induces apoptosis of colon cancer cells by inhibiting glutamine metabolism</article-title>. <source>J. Cell. Mol. Med.</source>
<volume>24</volume>, <fpage>3359</fpage>&#x02013;<lpage>3369</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.15009</pub-id>
<pub-id pub-id-type="pmid">31990147</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Heinzerling</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). in &#x0201c;<article-title>Chapter 48&#x02014;medication development for amphetamine dependence</article-title>,&#x0201d; in <source>Interventions for addiction</source>. Editor <person-group person-group-type="editor"><name><surname>Miller</surname><given-names>P. M.</given-names></name></person-group> (<publisher-loc>San Diego, CA</publisher-loc>: <publisher-name>Academic Press</publisher-name>), <fpage>459</fpage>&#x02013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-398338-1.00048-8</pub-id>
</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ho</surname><given-names>L. K.</given-names></name><name><surname>Ou</surname><given-names>J. C.</given-names></name><name><surname>Sun</surname><given-names>M. L.</given-names></name><name><surname>Sun</surname><given-names>C. M.</given-names></name></person-group> (<year>1995</year>). <article-title>Two rare alkaloids from Pratia nummularia</article-title>. <source>Planta Med.</source>
<volume>61</volume>, <fpage>567</fpage>&#x02013;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1055/s-2006-959376</pub-id>
<pub-id pub-id-type="pmid">17238111</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Nishida</surname><given-names>M.</given-names></name><name><surname>Miyauchi</surname><given-names>M.</given-names></name><name><surname>Kizu</surname><given-names>H.</given-names></name><name><surname>Kameda</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Homonojirimycin analogues and their glucosides from <italic>Lobelia sessilifolia</italic> and <italic>Adenophora</italic> spp. (Campanulaceae)</article-title>. <source>Carbohydr. Res.</source>
<volume>323</volume>, <fpage>73</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/s0008-6215(99)00246-3</pub-id>
<pub-id pub-id-type="pmid">10782288</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ishimaru</surname><given-names>K.</given-names></name><name><surname>Yonemitsu</surname><given-names>H.</given-names></name><name><surname>Shimomura</surname><given-names>K.</given-names></name></person-group> (<year>1991</year>). <article-title>Lobetyolin and lobetyol from hairy root culture of <italic>Lobelia inflata</italic>
</article-title>. <source>Phytochemistry</source>
<volume>30</volume>, <fpage>2255</fpage>&#x02013;<lpage>2257</lpage>. <pub-id pub-id-type="doi">10.1016/0031-9422(91)83624-T</pub-id>
</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Joshi</surname><given-names>S.</given-names></name><name><surname>Mishra</surname><given-names>D.</given-names></name><name><surname>Bisht</surname><given-names>G.</given-names></name><name><surname>Khetwal</surname><given-names>K. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Essential oil composition and antimicrobial activity of <italic>Lobelia</italic> pyramidalis Wall</article-title>. <source>EXCLI J.</source>
<volume>10</volume>, <fpage>274</fpage>&#x02013;<lpage>279</lpage>. <pub-id pub-id-type="pmid">29033708</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaczmarek</surname><given-names>F.</given-names></name><name><surname>Steinegger</surname><given-names>E.</given-names></name></person-group> (<year>1958</year>). <article-title>[Chromatographic studies on the basic fractions of Lobella cardinalis, especially of lobinaline and the new cardinalis alkaloid 2]</article-title>. <source>Pharm. Acta Helv.</source>
<volume>33</volume>, <fpage>852</fpage>&#x02013;<lpage>857</lpage>. <pub-id pub-id-type="pmid">13613932</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaczmarek</surname><given-names>F.</given-names></name><name><surname>Steinegger</surname><given-names>E.</given-names></name></person-group> (<year>1959</year>). <article-title>[Paper chromatographic separation of the alkaloids of <italic>Lobelia</italic> inflata from lobinaline, the main alkaloid of <italic>Lobelia</italic> cardinalis]</article-title>. <source>Pharm. Acta Helv.</source>
<volume>34</volume>, <fpage>330</fpage>&#x02013;<lpage>333</lpage>. <pub-id pub-id-type="pmid">14408314</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kelley</surname><given-names>Z. D.</given-names></name><name><surname>Rogers</surname><given-names>D. T.</given-names></name><name><surname>Littleton</surname><given-names>J. M.</given-names></name><name><surname>Lynn</surname><given-names>B. C.</given-names></name></person-group> (<year>2019</year>). <article-title>Microfluidic capillary zone electrophoresis mass spectrometry analysis of alkaloids in <italic>Lobelia</italic> cardinalis transgenic and mutant plant cell cultures</article-title>. <source>Electrophoresis</source>
<volume>40</volume>, <fpage>2921</fpage>&#x02013;<lpage>2928</lpage>. <pub-id pub-id-type="doi">10.1002/elps.201900220</pub-id>
<pub-id pub-id-type="pmid">31475363</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kesting</surname><given-names>J. R.</given-names></name><name><surname>Tolderlund</surname><given-names>I. L.</given-names></name><name><surname>Pedersen</surname><given-names>A. F.</given-names></name><name><surname>Witt</surname><given-names>M.</given-names></name><name><surname>Jaroszewski</surname><given-names>J. W.</given-names></name><name><surname>Staerk</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Piperidine and tetrahydropyridine alkaloids from <italic>Lobelia</italic> siphilitica and Hippobroma longiflora</article-title>. <source>J. Nat. Prod.</source>
<volume>72</volume>, <fpage>312</fpage>&#x02013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1021/np800743w</pub-id>
<pub-id pub-id-type="pmid">19206509</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klosa</surname><given-names>J.</given-names></name></person-group> (<year>1953</year>). <article-title>[Lobelanine synthesis under physiological conditions in the presence of light]</article-title>. <source>Pharmazie</source>
<volume>8</volume>, <fpage>1030</fpage>&#x02013;<lpage>1032</lpage>. <pub-id pub-id-type="pmid">13133721</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuo</surname><given-names>P. C.</given-names></name><name><surname>Hwang</surname><given-names>T. L.</given-names></name><name><surname>Lin</surname><given-names>Y. T.</given-names></name><name><surname>Kuo</surname><given-names>Y. C.</given-names></name><name><surname>Leu</surname><given-names>Y. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Chemical constituents from <italic>Lobelia</italic> chinensis and their anti-virus and anti-inflammatory bioactivities</article-title>. <source>Arch. Pharm. Res.</source>
<volume>34</volume>, <fpage>715</fpage>&#x02013;<lpage>722</lpage>. <pub-id pub-id-type="doi">10.1007/s12272-011-0503-7</pub-id>
<pub-id pub-id-type="pmid">21656355</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kursinszki</surname><given-names>L.</given-names></name><name><surname>Lud&#x000e1;nyi</surname><given-names>K.</given-names></name><name><surname>Sz&#x00151;ke</surname><given-names>&#x000c9;.</given-names></name></person-group> (<year>2008</year>). <article-title>LC-DAD and LC&#x02013;MS&#x02013;MS analysis of piperidine alkaloids of <italic>Lobelia</italic> inflata L. (<italic>In vitro</italic> and <italic>in vivo</italic>)</article-title>. <source>Chromatographia</source>
<volume>68</volume>, <fpage>27</fpage>. <pub-id pub-id-type="doi">10.1365/s10337-008-0628-0</pub-id>
</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lendle</surname><given-names>L.</given-names></name><name><surname>Richter</surname><given-names>R.</given-names></name></person-group> (<year>1950</year>). <article-title>[Pharmacologic analysis of the emetic and asthmalytic effects of <italic>Lobelia</italic> tinctures]</article-title>. <source>Klin. Wochenschr.</source>
<volume>28</volume>, <fpage>665</fpage>&#x02013;<lpage>667</lpage>. <pub-id pub-id-type="doi">10.1007/BF01485598</pub-id>
<pub-id pub-id-type="pmid">14804958</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>C. Y.</given-names></name><name><surname>Zhao</surname><given-names>L. M.</given-names></name><name><surname>Shi</surname><given-names>X. W.</given-names></name><name><surname>Zhang</surname><given-names>J. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Lobeline shows protective effects against MPTP-induced dopaminergic neuron death and attenuates behavior deficits in animals</article-title>. <source>Exp. Ther. Med.</source>
<volume>7</volume>, <fpage>375</fpage>&#x02013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2013.1413</pub-id>
<pub-id pub-id-type="pmid">24396408</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>X. J.</given-names></name><name><surname>Bao</surname><given-names>W. R.</given-names></name><name><surname>Leung</surname><given-names>C. H.</given-names></name><name><surname>Ma</surname><given-names>D. L.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Lu</surname><given-names>A. P.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Chemical structure and immunomodulating activities of an &#x003b1;-glucan purified from <italic>Lobelia</italic> chinensis lour</article-title>. <source>Molecules</source>
<volume>21</volume>, <fpage>779</fpage>. <pub-id pub-id-type="doi">10.3390/molecules21060779</pub-id>
</mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>C. A.</given-names></name><name><surname>Nuzzo</surname><given-names>P. A.</given-names></name><name><surname>Ranseen</surname><given-names>J. D.</given-names></name><name><surname>Kleven</surname><given-names>M. S.</given-names></name><name><surname>Guenthner</surname><given-names>G.</given-names></name><name><surname>Williams</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Lobeline effects on cognitive performance in adult ADHD</article-title>. <source>J. Atten. Disord.</source>
<volume>22</volume>, <fpage>1361</fpage>&#x02013;<lpage>1366</lpage>. <pub-id pub-id-type="doi">10.1177/1087054713497791</pub-id>
<pub-id pub-id-type="pmid">23966351</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mel&#x000e9;ndez</surname><given-names>E. N.</given-names></name><name><surname>Carreras</surname><given-names>L.</given-names></name><name><surname>Gij&#x000f3;n</surname><given-names>J. R.</given-names></name></person-group> (<year>1967</year>). <article-title>New alkaloid from <italic>Lobelia</italic> portoricensis urban</article-title>. <source>J. Pharm. Sci.</source>
<volume>56</volume>, <fpage>1677</fpage>&#x02013;<lpage>1680</lpage>. <pub-id pub-id-type="doi">10.1002/jps.2600561234</pub-id>
<pub-id pub-id-type="pmid">5626692</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>D. K.</given-names></name><name><surname>Crooks</surname><given-names>P. A.</given-names></name><name><surname>Zheng</surname><given-names>G.</given-names></name><name><surname>Grinevich</surname><given-names>V. P.</given-names></name><name><surname>Norrholm</surname><given-names>S. D.</given-names></name><name><surname>Dwoskin</surname><given-names>L. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters</article-title>. <source>J. Pharmacol. Exp. Ther.</source>
<volume>310</volume>, <fpage>1035</fpage>&#x02013;<lpage>1045</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.104.068098</pub-id>
<pub-id pub-id-type="pmid">15121762</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nair</surname><given-names>S. A.</given-names></name><name><surname>Sabulal</surname><given-names>B.</given-names></name><name><surname>Radhika</surname><given-names>J.</given-names></name><name><surname>Arunkumar</surname><given-names>R.</given-names></name><name><surname>Subramoniam</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Promising anti-diabetes mellitus activity in rats of &#x003b2;-amyrin palmitate isolated from Hemidesmus indicus roots</article-title>. <source>Eur. J. Pharmacol.</source>
<volume>734</volume>, <fpage>77</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2014.03.050</pub-id>
<pub-id pub-id-type="pmid">24726843</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nickell</surname><given-names>J. R.</given-names></name><name><surname>Krishnamurthy</surname><given-names>S.</given-names></name><name><surname>Norrholm</surname><given-names>S.</given-names></name><name><surname>Deaciuc</surname><given-names>G.</given-names></name><name><surname>Siripurapu</surname><given-names>K. B.</given-names></name><name><surname>Zheng</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Lobelane inhibits methamphetamine-evoked dopamine release <italic>via</italic> inhibition of the vesicular monoamine transporter-2</article-title>. <source>J. Pharmacol. Exp. Ther.</source>
<volume>332</volume>, <fpage>612</fpage>&#x02013;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.109.160275</pub-id>
<pub-id pub-id-type="pmid">19855096</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paz</surname><given-names>C.</given-names></name><name><surname>Becerra</surname><given-names>J.</given-names></name><name><surname>Silva</surname><given-names>M.</given-names></name><name><surname>Burgosa</surname><given-names>V.</given-names></name><name><surname>Heydenreich</surname><given-names>M.</given-names></name><name><surname>Schmidt</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>(-)-Pentylsedinine, a new alkaloid from the leaves of <italic>Lobelia</italic> tupa with agonist activity at nicotinic acetylcholine receptor</article-title>. <source>Nat. Prod. Commun.</source>
<volume>10</volume>, <fpage>1355</fpage>&#x02013;<lpage>1357</lpage>. <pub-id pub-id-type="pmid">26434115</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quon</surname><given-names>T.</given-names></name><name><surname>Lin</surname><given-names>L. C.</given-names></name><name><surname>Ganguly</surname><given-names>A.</given-names></name><name><surname>Tobin</surname><given-names>A. B.</given-names></name><name><surname>Milligan</surname><given-names>G.</given-names></name></person-group> (<year>2020</year>). <article-title>Therapeutic opportunities and challenges in targeting the orphan G protein-coupled receptor GPR35</article-title>. <source>ACS Pharmacol. Transl. Sci.</source>
<volume>3</volume>, <fpage>801</fpage>&#x02013;<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1021/acsptsci.0c00079</pub-id>
<pub-id pub-id-type="pmid">33073184</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raj</surname><given-names>H.</given-names></name><name><surname>Bakshi</surname><given-names>G. S.</given-names></name><name><surname>Tiwari</surname><given-names>R. R.</given-names></name><name><surname>Anand</surname><given-names>A.</given-names></name><name><surname>Paintal</surname><given-names>A. S.</given-names></name></person-group> (<year>2005</year>). <article-title>How does lobeline injected intravenously produce a cough?</article-title>. <source>Respir. Physiol. Neurobiol.</source>
<volume>145</volume>, <fpage>79</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.resp.2004.09.001</pub-id>
<pub-id pub-id-type="pmid">15652790</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roni</surname><given-names>M. A.</given-names></name><name><surname>Rahman</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Lobeline attenuates ethanol abstinence-induced depression-like behavior in mice</article-title>. <source>Alcohol</source>
<volume>61</volume>, <fpage>63</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.alcohol.2017.01.015</pub-id>
<pub-id pub-id-type="pmid">28554528</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roni</surname><given-names>M. A.</given-names></name><name><surname>Rahman</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>The effects of lobeline on depression-like behavior and hippocampal cell proliferation following chronic stress in mice</article-title>. <source>Neurosci. Lett.</source>
<volume>584</volume>, <fpage>7</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2014.10.009</pub-id>
<pub-id pub-id-type="pmid">25451721</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saldanha</surname><given-names>R. V.</given-names></name><name><surname>Cordeiro</surname><given-names>E.</given-names></name><name><surname>Costa</surname><given-names>E. G.</given-names></name><name><surname>de Melo</surname><given-names>M. E. L. O.</given-names></name></person-group> (<year>1959</year>). <article-title>Study of circulatory rate with lobeline (the alkaloid from <italic>Lobelia</italic> inflata)</article-title>. <source>Arq. Bras. Cardiol.</source>
<volume>12</volume>, <fpage>215</fpage>&#x02013;<lpage>222</lpage>. <pub-id pub-id-type="pmid">14440932</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>S&#x000e1;ntha</surname><given-names>E.</given-names></name><name><surname>Sperl&#x000e1;gh</surname><given-names>B.</given-names></name><name><surname>Zelles</surname><given-names>T.</given-names></name><name><surname>Zsilla</surname><given-names>G.</given-names></name><name><surname>T&#x000f3;th</surname><given-names>P. T.</given-names></name><name><surname>Lendvai</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Multiple cellular mechanisms mediate the effect of lobeline on the release of norepinephrine</article-title>. <source>J. Pharmacol. Exp. Ther.</source>
<volume>294</volume>, <fpage>302</fpage>&#x02013;<lpage>307</lpage>. <pub-id pub-id-type="pmid">10871326</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Santosa</surname><given-names>M. H.</given-names></name><name><surname>Herzog</surname><given-names>R.</given-names></name><name><surname>Voelter</surname><given-names>W.</given-names></name></person-group> (<year>1986</year>). <article-title>Antitumor activity of the hot water extract of <italic>Lobelia</italic> chinensis</article-title>. <source>Planta Med.</source>
<volume>555</volume>, <fpage>555</fpage>. <pub-id pub-id-type="doi">10.1055/s-2007-969368</pub-id>
</mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Mikami</surname><given-names>M.</given-names></name></person-group> (<year>1962</year>). <article-title>[Studies on the components of <italic>Lobelia</italic> sessilifolia lamb. II. On the periodateoxidation of a new glucofructan &#x0201c;sessilifolan&#x0201d;]</article-title>. <source>Yakugaku Zasshi</source>
<volume>82</volume>, <fpage>1520</fpage>&#x02013;<lpage>1522</lpage>. <pub-id pub-id-type="pmid">13986633</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Mikami</surname><given-names>M.</given-names></name><name><surname>Ueda</surname><given-names>H.</given-names></name></person-group> (<year>1961</year>). <article-title>[Studies on the components of <italic>Lobelia</italic> sessilifolia Lamb. I. Isolation of a new glucofructan]</article-title>. <source>Yakugaku Zasshi</source>
<volume>81</volume>, <fpage>1626</fpage>&#x02013;<lpage>1628</lpage>. <pub-id pub-id-type="pmid">14497331</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Du</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Lobetyol activate MAPK pathways associated with G1/S cell cycle arrest and apoptosis in MKN45 cells <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>Biomed. Pharmacother.</source>
<volume>81</volume>, <fpage>120</fpage>&#x02013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2016.03.046</pub-id>
<pub-id pub-id-type="pmid">27261585</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shibano</surname><given-names>M.</given-names></name><name><surname>Tsukamoto</surname><given-names>D.</given-names></name><name><surname>Masuda</surname><given-names>A.</given-names></name><name><surname>Tanaka</surname><given-names>Y.</given-names></name><name><surname>Kusano</surname><given-names>G.</given-names></name></person-group> (<year>2001</year>). <article-title>Two new pyrrolidine alkaloids, radicamines A and B, as inhibitors of alpha-glucosidase from <italic>Lobelia</italic> chinensis lour</article-title>. <source>Chem. Pharm. Bull.</source>
<volume>49</volume>, <fpage>1362</fpage>&#x02013;<lpage>1365</lpage>. <pub-id pub-id-type="doi">10.1248/cpb.49.1362</pub-id>
</mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spurny</surname><given-names>R.</given-names></name><name><surname>Debaveye</surname><given-names>S.</given-names></name><name><surname>Farinha</surname><given-names>A.</given-names></name><name><surname>Veys</surname><given-names>K.</given-names></name><name><surname>Vos</surname><given-names>A. M.</given-names></name><name><surname>Gossas</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the &#x003b1;7 nicotinic acetylcholine receptor</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>
<volume>112</volume>, <fpage>E2543</fpage>&#x02013;<lpage>E2552</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1418289112</pub-id>
<pub-id pub-id-type="pmid">25918415</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stead</surname><given-names>L. F.</given-names></name><name><surname>Hughes</surname><given-names>J. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Lobeline for smoking cessation</article-title>. <source>Cochrane Database Syst. Rev.</source>
<volume>2012</volume>, <fpage>CD000124</fpage>. <pub-id pub-id-type="doi">10.1002/14651858.CD000124.pub2</pub-id>
</mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steinegger</surname><given-names>E.</given-names></name><name><surname>Egger</surname><given-names>F.</given-names></name></person-group> (<year>1952</year>). <article-title>[Alkaloids of <italic>Lobelia</italic> symphilitica L.]</article-title>. <source>Pharm. Acta Helv.</source>
<volume>27</volume>, <fpage>113</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="pmid">14957568</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steinegger</surname><given-names>E.</given-names></name><name><surname>Grutter</surname><given-names>H.</given-names></name></person-group> (<year>1950</year>). <article-title>[Lurenine, a new crystallized alkaloid from <italic>Lobelia</italic> urens]</article-title>. <source>Pharm. Acta Helv.</source>
<volume>25</volume>, <fpage>276</fpage>&#x02013;<lpage>277</lpage>. <pub-id pub-id-type="pmid">14780823</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steinegger</surname><given-names>E.</given-names></name><name><surname>Ochsner</surname><given-names>F.</given-names></name></person-group> (<year>1956</year>). <article-title>[Alkaloids of <italic>Lobelia</italic> salicifolia sweet. I]</article-title>. <source>Pharm. Acta Helv.</source>
<volume>31</volume>, <fpage>89</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="pmid">13322582</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Subarnas</surname><given-names>A.</given-names></name><name><surname>Oshima</surname><given-names>Y.</given-names></name><name><surname>Sidik</surname></name><name><surname>Ohizumi</surname><given-names>Y.</given-names></name></person-group> (<year>1992</year>). <article-title>An antidepressant principle of <italic>Lobelia inflata</italic> L. (Campanulaceae)</article-title>. <source>J. Pharm. Sci.</source>
<volume>81</volume>, <fpage>620</fpage>&#x02013;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1002/jps.2600810705</pub-id>
<pub-id pub-id-type="pmid">1403691</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Subarnas</surname><given-names>A.</given-names></name><name><surname>Tadano</surname><given-names>T.</given-names></name><name><surname>Kisara</surname><given-names>K.</given-names></name><name><surname>Ohizumi</surname><given-names>Y.</given-names></name></person-group> (<year>1993a</year>). <article-title>An alpha-adrenoceptor-mediated mechanism of hypoactivity induced by beta-amyrin palmitate</article-title>. <source>J. Pharm. Pharmacol.</source>
<volume>45</volume>, <fpage>1006</fpage>&#x02013;<lpage>1008</lpage>. <pub-id pub-id-type="doi">10.1111/j.2042-7158.1993.tb05649.x</pub-id>
<pub-id pub-id-type="pmid">7908030</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Subarnas</surname><given-names>A.</given-names></name><name><surname>Tadano</surname><given-names>T.</given-names></name><name><surname>Nakahata</surname><given-names>N.</given-names></name><name><surname>Arai</surname><given-names>Y.</given-names></name><name><surname>Kinemuchi</surname><given-names>H.</given-names></name><name><surname>Oshima</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>1993b</year>). <article-title>A possible mechanism of antidepressant activity of beta-amyrin palmitate isolated from <italic>Lobelia</italic> inflata leaves in the forced swimming test</article-title>. <source>Life Sci.</source>
<volume>52</volume>, <fpage>289</fpage>&#x02013;<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1016/0024-3205(93)90220-w</pub-id>
<pub-id pub-id-type="pmid">8423710</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Subarnas</surname><given-names>A.</given-names></name><name><surname>Tadano</surname><given-names>T.</given-names></name><name><surname>Oshima</surname><given-names>Y.</given-names></name><name><surname>Kisara</surname><given-names>K.</given-names></name><name><surname>Ohizumi</surname><given-names>Y.</given-names></name></person-group> (<year>1993c</year>). <article-title>Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from <italic>Lobelia</italic> inflata leaves</article-title>. <source>J. Pharm. Pharmacol.</source>
<volume>45</volume>, <fpage>545</fpage>&#x02013;<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1111/j.2042-7158.1993.tb05596.x</pub-id>
<pub-id pub-id-type="pmid">8103103</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tamboli</surname><given-names>A. M.</given-names></name><name><surname>Rub</surname><given-names>R. A.</given-names></name><name><surname>Ghosh</surname><given-names>P.</given-names></name><name><surname>Bodhankar</surname><given-names>S. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Antiepileptic activity of lobeline isolated from the leaf of <italic>Lobelia</italic> nicotianaefolia and its effect on brain GABA level in mice</article-title>. <source>Asian Pac. J. Trop. Biomed.</source>
<volume>2</volume>, <fpage>537</fpage>&#x02013;<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1016/S2221-1691(12)60092-6</pub-id>
<pub-id pub-id-type="pmid">23569966</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Terry</surname><given-names>A. V.</given-names></name><name><surname>Williamson</surname><given-names>R.</given-names></name><name><surname>Gattu</surname><given-names>M.</given-names></name><name><surname>Beach</surname><given-names>J. W.</given-names></name><name><surname>McCurdy</surname><given-names>C. R.</given-names></name><name><surname>Sparks</surname><given-names>J. A.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine</article-title>. <source>Neuropharmacology</source>
<volume>37</volume>, <fpage>93</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/s0028-3908(97)00142-1</pub-id>
<pub-id pub-id-type="pmid">9680262</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tondeur</surname><given-names>R.</given-names></name><name><surname>Charlier</surname><given-names>R.</given-names></name></person-group> (<year>1950</year>). <article-title>[Extraction and pharmacological studies of alkaloids of <italic>Lobelia</italic> giberroa (Hemsl.)]</article-title>. <source>Arch. Int. Pharmacodyn. Ther.</source>
<volume>83</volume>, <fpage>91</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="pmid">15426371</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vartak</surname><given-names>A. P.</given-names></name><name><surname>Gabriela Deaciuc</surname><given-names>A.</given-names></name><name><surname>Dwoskin</surname><given-names>L. P.</given-names></name><name><surname>Crooks</surname><given-names>P. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Quinlobelane: a water-soluble lobelane analogue and inhibitor of VMAT2</article-title>. <source>Bioorg. Med. Chem. Lett.</source>
<volume>20</volume>, <fpage>3584</fpage>&#x02013;<lpage>3587</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2010.04.117</pub-id>
<pub-id pub-id-type="pmid">20494575</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vartak</surname><given-names>A. P.</given-names></name><name><surname>Nickell</surname><given-names>J. R.</given-names></name><name><surname>Chagkutip</surname><given-names>J.</given-names></name><name><surname>Dwoskin</surname><given-names>L. P.</given-names></name><name><surname>Crooks</surname><given-names>P. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Pyrrolidine analogues of lobelane: relationship of affinity for the dihydrotetrabenazine binding site with function of the vesicular monoamine transporter 2 (VMAT2)</article-title>. <source>J. Med. Chem.</source>
<volume>52</volume>, <fpage>7878</fpage>&#x02013;<lpage>7882</lpage>. <pub-id pub-id-type="doi">10.1021/jm900770h</pub-id>
<pub-id pub-id-type="pmid">19691331</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Qu</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Isolation and bioactive evaluation of flavonoid glycosides from <italic>Lobelia</italic> chinensis Lour using two-dimensional liquid chromatography combined with label-free cell phenotypic assays</article-title>. <source>J. Chromatogr. A.</source>
<volume>1601</volume>, <fpage>224</fpage>&#x02013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1016/j.chroma.2019.04.073</pub-id>
<pub-id pub-id-type="pmid">31101464</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wei</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Discovery of 2H-Chromen-2-one derivatives as G protein-coupled receptor-35 agonists</article-title>. <source>J. Med. Chem.</source>
<volume>60</volume>, <fpage>362</fpage>&#x02013;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.6b01431</pub-id>
<pub-id pub-id-type="pmid">27976894</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weinges</surname><given-names>K.</given-names></name><name><surname>B&#x000e4;hr</surname><given-names>W.</given-names></name><name><surname>Ebert</surname><given-names>W.</given-names></name><name><surname>Kloss</surname><given-names>P.</given-names></name></person-group> (<year>1972</year>). <article-title>[Norlobelanidine, the main alkaloid from <italic>Lobelia</italic> polyphylla Hook and Arn]</article-title>. <source>Justus Liebigs Ann. Chem.</source>
<volume>756</volume>, <fpage>177</fpage>&#x02013;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1002/jlac.19727560119</pub-id>
<pub-id pub-id-type="pmid">5066165</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williams</surname><given-names>H. J.</given-names></name><name><surname>Ray</surname><given-names>A. C.</given-names></name><name><surname>Kim</surname><given-names>H. L.</given-names></name></person-group> (<year>1987</year>). <article-title>DELTA.3-Piperideine alkaloids from the toxic plant <italic>Lobelia</italic> berlandieri</article-title>. <source>J. Agric. Food Chem.</source>
<volume>35</volume>, <fpage>19</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1021/jf00073a005</pub-id>
</mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Yu</surname><given-names>K.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Kuo</surname><given-names>Y. P.</given-names></name><name><surname>Segerberg</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors</article-title>. <source>J. Physiol.</source>
<volume>576</volume>, <fpage>103</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2006.114645</pub-id>
<pub-id pub-id-type="pmid">16825297</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Shen</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Lou</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Chemical constituents of <italic>Lobelia</italic> chinensis</article-title>. <source>Fitoterapia</source>
<volume>93</volume>, <fpage>168</fpage>&#x02013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.fitote.2014.01.007</pub-id>
<pub-id pub-id-type="pmid">24444893</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zeng</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>He</surname><given-names>W.</given-names></name><name><surname>Qin</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Tao</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>NPASS: natural product activity and species source database for natural product research, discovery and tool development</article-title>. <source>Nucleic Acids Res.</source>
<volume>46</volume>, <fpage>D1217</fpage>&#x02013;<lpage>D1222</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx1026</pub-id>
<pub-id pub-id-type="pmid">29106619</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.-Z.</given-names></name><name><surname>Wang</surname><given-names>J.-C.</given-names></name><name><surname>Zhou</surname><given-names>S.-H.</given-names></name></person-group> (<year>1990</year>). <article-title>Alkaloids triterpenoids of <italic>Lobelia</italic> davidii</article-title>. <source>Phytochemistry</source>
<volume>29</volume>, <fpage>1353</fpage>&#x02013;<lpage>1354</lpage>. <pub-id pub-id-type="doi">10.1016/0031-9422(90)85468-U</pub-id>
</mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group> (<year>2020</year>). <article-title>Chemical structure elucidation of an inulin-type fructan isolated from <italic>Lobelia</italic> chinensis lour with anti-obesity activity on diet-induced mice</article-title>. <source>Carbohydr. Polym.</source>
<volume>240</volume>, <fpage>116357</fpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2020.116357</pub-id>
<pub-id pub-id-type="pmid">32475601</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>G.</given-names></name><name><surname>Dwoskin</surname><given-names>L. P.</given-names></name><name><surname>Crooks</surname><given-names>P. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Vesicular monoamine transporter 2: role as a novel target for drug development</article-title>. <source>AAPS J.</source>
<volume>8</volume>, <fpage>E682</fpage>&#x02013;<lpage>E692</lpage>. <pub-id pub-id-type="doi">10.1208/aapsj080478</pub-id>
<pub-id pub-id-type="pmid">17233532</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>G.</given-names></name><name><surname>Dwoskin</surname><given-names>L. P.</given-names></name><name><surname>Deaciuc</surname><given-names>A. G.</given-names></name><name><surname>Norrholm</surname><given-names>S. D.</given-names></name><name><surname>Crooks</surname><given-names>P. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter</article-title>. <source>J. Med. Chem.</source>
<volume>48</volume>, <fpage>5551</fpage>&#x02013;<lpage>5560</lpage>. <pub-id pub-id-type="doi">10.1021/jm0501228</pub-id>
<pub-id pub-id-type="pmid">16107155</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Q.</given-names></name><name><surname>Fang</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>Investigation of the mechanisms of neuroprotection mediated by <italic>Lobelia</italic> species <italic>via</italic> computational network pharmacology and molecular modeling</article-title>. <source>Res. Sq.</source>
<pub-id pub-id-type="doi">10.21203/rs.3.rs-61537/v1</pub-id>
</mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Guo</surname><given-names>F.</given-names></name><name><surname>Yan</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Two-dimensional liquid chromatography coupled with mass spectrometry for the analysis of <italic>Lobelia</italic> chinensis Lour. using an ESI/APCI multimode ion source</article-title>. <source>J. Sep. Sci.</source>
<volume>31</volume>, <fpage>2388</fpage>&#x02013;<lpage>2394</lpage>. <pub-id pub-id-type="doi">10.1002/jssc.200700685</pub-id>
<pub-id pub-id-type="pmid">18604839</pub-id></mixed-citation></ref></ref-list></back></article>